Literature DB >> 24200591

Genetic analysis of human rhinovirus species A to C detected in patients with acute respiratory infection in Kumamoto prefecture, Japan 2011-2012.

Naoko Kiyota1, Miho Kobayashi2, Hiroyuki Tsukagoshi2, Akihide Ryo3, Seiya Harada1, Takashi Kusaka4, Masatsugu Obuchi5, Naoki Shimojo6, Masahiro Noda7, Hirokazu Kimura8.   

Abstract

We performed detailed genetic analysis of the VP4/VP2 coding region in human rhinovirus species A to C (HRV-ABC) strains detected in patients with a variety of acute respiratory infections in Kumamoto, Japan in the period 2011-12. The phylogenetic tree and evolutionary timescale were obtained by the Bayesian Markov chain Monte Carlo method. Phylogenetic analyses showed that the present HRV-A, -B, and -C strains belonged to 25, 4, and 18 genotypes, respectively. Some new genotypes were confirmed as prevalent strains of HRV-C. An ancestor of the present HRV-ABCs could be dated back to about 20,000 years ago. The present HRV-A and -C strains have wide genetic divergence (pairwise distance >0.2) with rapid evolutionary rates (around 7 × 10(-4) to 4 × 10(-3)substitutions/site/year). Over 100 sites were found to be under negative selection, while no positively selected sites were found in the analyzed region. No evidence of recombination events was found in this region of the present strains. Our results indicate that the present HRV strains have rapidly evolved and subsequently diverged over a long period into multiple genotypes.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute respiratory infection; Bayesian Markov chain Monte Carlo method; Human rhinovirus; Pairwise distance; VP4/VP2 region

Mesh:

Year:  2013        PMID: 24200591     DOI: 10.1016/j.meegid.2013.10.024

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  7 in total

Review 1.  Epidemiology of virus-induced asthma exacerbations: with special reference to the role of human rhinovirus.

Authors:  Takeshi Saraya; Daisuke Kurai; Haruyuki Ishii; Anri Ito; Yoshiko Sasaki; Shoichi Niwa; Naoko Kiyota; Hiroyuki Tsukagoshi; Kunihisa Kozawa; Hajime Goto; Hajime Takizawa
Journal:  Front Microbiol       Date:  2014-05-26       Impact factor: 5.640

2.  Characterization of rhinovirus C from a 4-year-old boy with acute onset dilated cardiomyopathy in Jakarta, Indonesia.

Authors:  Ageng Wiyatno; E S Zul Febrianti; Aghnianditya Kresno Dewantari; Khin Saw Myint; Dodi Safari; Nikmah Salamia Idris
Journal:  JMM Case Rep       Date:  2018-02-01

3.  Epidemiological analysis and follow-up of human rhinovirus infection in children with asthma exacerbation.

Authors:  Shou-Yan Zheng; Li-Li Wang; Luo Ren; Jian Luo; Wei Liao; En-Mei Liu
Journal:  J Med Virol       Date:  2017-10-27       Impact factor: 2.327

4.  Genetic diversity and epidemiology of human rhinovirus among children with severe acute respiratory tract infection in Guangzhou, China.

Authors:  Wanwei Li; Bo Yu; Jijian Zhou; Yanlan Wang; Bao Xue; Jialong Pan; Yanhong Ran; Xiaoping Yang; Xiaoping Wang; Fang Yang; Hongjian Li
Journal:  Virol J       Date:  2021-08-23       Impact factor: 4.099

5.  Phylogenetic characterization of rhinoviruses from infants in Sarlahi, Nepal.

Authors:  Jane Kuypers; Garrett A Perchetti; Helen Y Chu; Kira L Newman; Joanne Katz; Subarna K Khatry; Steven C LeClerq; Keith R Jerome; James M Tielsch; Janet A Englund
Journal:  J Med Virol       Date:  2019-08-21       Impact factor: 2.327

6.  Molecular Epidemiology of Human Rhinovirus From 1-Year Surveillance Within a School Setting in Rural Coastal Kenya.

Authors:  Martha M Luka; Everlyn Kamau; Irene Adema; Patrick K Munywoki; Grieven P Otieno; Elijah Gicheru; Alex Gichuki; Nelson Kibinge; Charles N Agoti; D James Nokes
Journal:  Open Forum Infect Dis       Date:  2020-08-27       Impact factor: 3.835

Review 7.  Understanding Rhinovirus Circulation and Impact on Illness.

Authors:  Camille Esneau; Alexandra Cate Duff; Nathan W Bartlett
Journal:  Viruses       Date:  2022-01-13       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.